Viewing StudyNCT01162785



Ignite Creation Date: 2024-05-05 @ 10:41 PM
Last Modification Date: 2024-10-26 @ 10:22 AM
Study NCT ID: NCT01162785
Status: COMPLETED
Last Update Posted: 2016-11-28
First Post: 2010-07-13

Brief Title: 1B Intravesical Administration of SCH 721015 Ad-IFNa in Admixture With SCH 209702 Syn3 for The Treatment of BCG Refractory Superficial Bladder Cancer
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Bladder Cancer
Keywords:
Name View
BCG Refractory Superficial Bladder Cancer View
SCH 721015 View
Syn3 View
novel excipient View
interferon -alpha-2b View
Intravesical View
urine IFNa View
transitional cell carcinoma of the bladder View
superficial non-muscle invasive tumor View